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Summary: The process whereby early exposure to an adverse environment has an influence on later 
life outcomes has been called ‘early life programming’. Whilst epidemiological evidence for this has 
been available for decades, only in recent years have the mechanisms, in particular epigenetic 
modifications, for this process begun to be elucidated. We discuss the evidence for early life 
programming, the possible mechanisms, how effects may be transmitted across generations, and 
conclude by looking at some examples relevant to general paediatrics.   
 
Childhood and later disease risk 
The fact that early exposures might have an influence on health outcomes later in life has been 
recognised since the first half of the twentieth century. In 1933 Kermack and colleagues [1]  analysed 
historic death rates data for England, Scotland and Sweden and noted that “the figures behave as if the 
expectation of life was determined by the conditions which existed during the child's earlier years”. 
They further speculated that “improvement in infantile mortality is dependent in large measure on 
improvement in maternal health”. In 1977 Forsdahl [2] correlated higher infant mortality in Norway 
with a later increased risk of death from cardiovascular causes. He proposed poverty in childhood and 
adolescence followed by prosperity as a risk factor for cardiovascular disease (CVD), and 
hypothesised that “some form of permanent damage caused by a nutritional deficit” might be 
involved.  
 
The Barker hypothesis 
Ongoing epidemiological work continued to show an association between low birthweight and a 
higher risk of CVD, stroke, the metabolic syndrome and osteoporosis in later life. Barker and 
colleagues, in a series of papers (e.g.[3]) argued that a fetus faced with undernutrition slows its growth 
rate to reduce its nutritional requirements, but this period of undernutrition might also lead to reduced 
function in key organs, altered metabolic and endocrine feedback loops, and an increased 
vulnerability to adverse environmental stressors. Over time these ideas have developed into the 
DOHaD (Developmental Origins of Health and Disease) concept, whereby early life exposures are 
thought to lead to “programming” of cardiovascular, neuroendocrine and metabolic systems, 
predisposing the individual to later life non-communicable diseases (NCD).  
 
Some authors have put this concept of programming within an evolutionary paradigm with the idea of 
the “predictive adaptive response” [4]. They argue that these stereotyped responses to an adverse early 
life environment are adaptive in the short-term, and particularly when individuals continue to live in a 
resource poor environment represent the best way to guarantee they reach reproductive age 
themselves. However, in a resource rich postnatal environment such as that of the developed world, 
these programmed changes might have the (unanticipated) effect of predisposing affected individuals 
to an increased risk of NCDs in adulthood (Figure 1). Regardless of the validity of the idea of a 
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“predictive adaptive response”, in recent years focus has shifted from extremes of birthweight to how 
programming might occur across all pregnancies and in individuals with birthweights within the 
normal range. 
  
Adverse environments in utero  
A large number of human cohort studies have demonstrated a link between lower birthweight 
(suggesting in utero exposure to an adverse environment) and a higher risk of CVD, stroke, insulin 
resistance and type 2 diabetes in adulthood, in a variety of settings in the developed and developing 
world,[4] and these findings have been replicated extensively in animal studies.[5] In addition to 
cardiometabolic sequelae, low birthweight has also been related to increased risk of death from 
infectious causes,[6] altered immune function, an increased risk of asthma and atopic dermatitis,[7] 
and neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD) [8] and 
schizophrenia.[9] The importance of the early life environment in influencing later disease risk has 
been highlighted by a recent analysis showing that the greater the number of adverse early-life risk 
factors an individual is exposed to, the greater the risk of overweight and obesity in childhood.[10] 
 
Although many of the original studies focussed on poor maternal nutrition as a major contributor to 
low birthweight, a wide variety of endogenous and exogenous factors are now recognised to influence 
cardiovascular, respiratory, metabolic and neurodevelopmental outcomes in offspring. Animal models 
using uterine artery ligation to create in utero hypoxia have shown that offspring are at risk of 
cardiovascular and metabolic complications.[5] Similarly, human studies suggest that maternal 
hypertension [11] and cigarette smoking,[12] which both lead to in utero hypoxia, also increase the 
risk of CVD. Although the original epidemiological studies did not distinguish between intra-uterine 
growth restriction (IUGR) and prematurity as a cause of low birthweight, it is increasingly realised 
that prematurity itself is a major risk factor for the development of NCDs (reviewed in [13, 14]). 
Interestingly, maternal obesity/overnutrition during pregnancy, which commonly leads to increased 
birthweight, also associates with adverse offspring health outcomes which, perhaps surprisingly, are 
similar to those seen with undernutrition. In animal and human studies maternal overnutrition is 
linked with an increased predisposition to obesity, hypertension, hyperinsulinaemia, hyperglycaemia, 
and increased plasma triglycerides, cholesterol and leptin in offspring.[15] In humans, maternal 
obesity  has also been linked to an increased risk of ADHD and problems with emotional regulation 
[16] and with premature mortality from cardiovascular events.[17]  
 
Prenatal glucocorticoid overexposure is also associated with programmed effects. Epidemiological 
studies show that pregnant mothers exposed to a significant life event (death of a loved one, exposure 
to terrorism or a natural disaster) give birth to infants with a lower birthweight,[18] who have an 
increased risk of impaired cognition.[19] Maternal stress is also associated with effects on 
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neurodevelopment in neonates, manifesting as lower scores on neonatal assessment,[20] behavioural 
and emotional problems at the age of four,[21] decreased grey matter density [22] and lower cognitive 
and language abilities in childhood.[19] The children of mothers treated with glucocorticoids because 
of a risk that the unborn child had congenital adrenal hyperplasia appear to be at risk of worse 
cognitive function than controls.[23] Studies in rodent, sheep and non-human primate models show an 
association between antenatal glucocorticoid exposure (exogenous and endogenous), raised blood 
pressure (BP) and altered glucose-insulin homeostasis, neuro-endocrine function and behaviour.[24] 
Finally, a variety of other adverse environmental factors have been shown to impact on 
neurodevelopmental outcomes: maternal infection, alcohol consumption, recreational drug use, 
treatment with certain medications (e.g. sodium valproate) and prenatal exposure to toxins such as 
arsenic and lead have all been associated with an increased risk of adverse neurodevelopmental 
outcomes including schizophrenia and autism [reviewed in 25]. 
 
Postnatal factors which influence the risk of developing NCD  
The long-term consequences of early exposures are modulated by the postnatal environment. Early 
postnatal growth patterns influence disease risk, for example, in a trial involving a cohort of small for 
gestational age (SGA) infants, those randomised to a high protein formula who had greater weight 
gain had significantly higher BP at 6-8 years [26] and conditional gains in abdominal circumference 
also associate with higher childhood BP.[27] Three large cohort studies have shown that excessive 
weight gain in infancy is associated with an increased risk of greater total fat mass and percentage 
body fat, lower insulin sensitivity and higher systolic BP in childhood.[28] These relationships are 
complex however; extensive data from the Helsinki birth cohort study and the Hertfordshire cohort 
show that low weight at one year of age but an early ‘adiposity rebound’ associates with a higher risk 
of CVD and type 2 diabetes and that boys who were born small but were tall at school entry had a 6-
year reduction in lifespan.[29, 30] These data are supported by animal studies, for example in mice, 
poor fetal growth resulting from maternal protein restriction, followed by rapid postnatal growth 
results in reduced life span.[31]  
 
Because of phenotypic similarities between adults born SGA and prematurely, some researchers have 
postulated that whilst in low birthweight infants the adverse environment is experienced in utero, in 
preterm infants these environmental challenges occur postnatally.[32] Preterm birth, regardless of 
birthweight relative to gestation (i.e. without evidence of in utero growth restriction), has in itself has 
been associated with a reduction in insulin sensitivity,[32, 33] changes in the endocrine regulation of 
childhood growth,[34] and  increased adiposity.[35] Similar to SGA infants, rapid early weight gain 
may also be detrimental for preterm babies: in a randomised controlled trial which allocated preterm 
infants to high or lower nutrient diet, those with the most rapid weight gain in the first two weeks of 
life showed evidence of insulin resistance in adolescence [36] and other studies report that upward 
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centile crossing for weight in infancy [37] and childhood [38] are associated with insulin resistance 
and higher BP.  
 
However, it may not only be low birthweight and preterm infants who are susceptible to the 
influences of postnatal diet. Maternal obesity and overnutrition are also risk factors for childhood 
obesity, and this is exacerbated by a high energy diet in infancy.[39] In rodent models of maternal 
overfeeding, offspring are predisposed to obesity and metabolic abnormalities, and this effect is 
amplified when the offspring are exposed to high-fat diets following weaning.[40] Finally, there may 
be an important influence of childhood exposure to stressful experiences; severe stress during 
childhood is a well-known risk factor for both mental health disorders and CVD.[41]  
 
Mechanisms 
A consistent criticism of the DOHaD concept has been the difficulty in disentangling the putative 
effects of programming from the shared genetic and environmental influences affecting offspring. 
Nevertheless, studies in humans and in animal models have attempted to address a number of 
potential mechanisms. 
 
Programming may exercise its long-term effects via structural changes in organs. Human infants born 
after IUGR have reduced numbers of nephrons, [42] increasing the risk of hypertension in adulthood. 
Prematurity has also been associated with a reduction in capillary density, thought to be related to an 
increased risk of hypertension.[43] In animal models, antenatal glucocorticoid exposure leads to 
reduced nephron number and changes in cardiac noradrenergic innervation [24] together with a 
reduction in pancreatic beta-cell growth, a risk factor for type 2 diabetes.[44] Maternal obesity 
impacts on offspring body fat and muscle composition, which may contribute towards the 
development of insulin resistance.[15] Antenatal glucocorticoids affect hippocampal growth, and 
associate with delayed maturation of neurons, myelination, glia and vasculature.[24] 
 
Programming may also lead to longer term hormonal changes. In rodents, prenatal glucocorticoid 
excess affects the renin-angiotensin-aldosterone system and both undernutrition and glucocorticoid 
overexposure affect glucose-insulin homeostasis in a variety of animal models.[24] Maternal 
obesity/overnutrition during pregnancy leads to programmed alterations in the brain, in particular the 
hypothalamus, which may impact on appetite control.[15] Importantly, nutrient deficiencies, low 
birthweight and maternal stress affect hypothalamic-pituitary-adrenal (HPA) axis development [45] 
and this may be a key mechanism linking the early life environment with later disease risk. Exposure 
to an adverse in utero environment is associated with altered HPA axis activity in childhood and 
adulthood [46, 47] which may relate to the higher risk of neurodevelopmental problems [48] and 
changes in HPA axis activity are also a risk factor for CVD in later life.[46] Finally, re-setting of the 
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HPA axis affects the development of key glucocorticoid responsive organs such as the kidneys, 
adipose tissue and pancreas, [45] linking structural and hormonal changes in the programming of later 
life disease. 
 
There has been much interest in recent years in the role of epigenetic modifications in early life 
programming. Epigenetic modifications lead to changes in gene expression that are not explained by 
changes in DNA sequence, and during normal development, key developmental stages are 
characterised by epigenetic modifications that have the potential to be altered/disrupted by 
environmental cues. Epigenetic modifications include DNA methylation, histone marks and small, 
non-coding RNAs.  
 
DNA methylation is crucial for normal development and is involved in cell differentiation, genomic 
imprinting and X chromosome silencing. A growing number of studies have described alterations in 
DNA methylation and gene expression in association with early life exposures. Adults exposed in 
utero to severe calorie restriction during the Dutch Hunger Winter of 1944/5 have reduced 
methylation at regions controlling the expression of the insulin-like growth factor 2 (IGF2), a key 
hormone in growth and development [49] and individuals exposed to an unbalanced diet in utero 
showed differential methylation at 11β-hydroxysteroid dehydrogenase type 2 (important in the 
regulation of BP), the glucocorticoid receptor (GR) and IGF2, in association with a risk of obesity and 
hypertension.[50] In rats, undernutrition and/or prenatal glucocorticoid overexposure influence DNA 
methylation of GR and IGF2 [51, 52] suggesting a mechanism by which adverse early life 
environments may affect hormonal homeostasis in offspring. Studies also suggest an association 
between maternal anxiety/depression and altered DNA methylation at genes important in HPA axis 
regulation and mood in the offspring.[53] Such effects are also seen with postnatal exposures: 
experience of childhood abuse associates with altered HPA and autonomic responses to stress and 
with altered DNA methylation in both peripheral blood and brain.[54-56]  
 
DNA is organised around histones which can also be modified to control gene transcription. The 
development of glucose-insulin dyshomeostasis in rats after IUGR is associated with alterations in 
histone modifications at the Pdx1 gene, a transcription factor regulating pancreatic development and 
β-cell differentiation, and additionally at the hepatic transcription factor  Hnf4α, which associates with 
insulin resistance.[57] Gene expression can also be modulated by non-coding RNAs which are posited 
to regulate gene expression by transcriptional and post-transcriptional gene silencing. Studies in 
adipose tissue of rats exposed to a low protein diet in utero and in humans born at low birthweight 
have demonstrated persistent changes in a specific micro-RNA which may influence adipocyte 




Nevertheless, although studies have shown epigenetic changes in association with early life 
exposures, the degree to which such changes are adaptive within the life course, occur as a 
consequence of the induced disease state or represent a pathophysiological response to adverse 
exposures remains to be determined as the mechanism(s) of these changes are elucidated. Recent 
studies suggesting that a significant proportion of neonatal DNA methylation changes are determined 
by genotype rather than environment [59] highlight the difficulties in distinguishing genetic from 
epigenetic inheritance.  
 
Intergenerational transmission of programmed effects 
In addition to the effects of early life exposures on individual outcomes, there is increasing evidence 
that the effects of early life exposures may be transmitted non-genomically to subsequent 
generations.[60] Three human cohort studies suggest possible instances of the transmission of 
programmed effects, two through the female line [61, 62] and one patrilineally.[63] In this latter 
study, Kaati et al used detailed historical information on cohorts from Sweden which showed that 
food availability during the grandparents’ childhood influenced the risk of CVD and diabetes in their 
grand-offspring. Intergenerational effects of early life environmental interventions have also been 
shown in a number of animal models [reviewed in 60]. Potential explanations for the transmission of 
programming effects across generations include persisting adverse environmental conditions, adverse 
in utero experiences resulting in programming effects in a female which then influence her own 
pregnancy or effects that are transmissible through gametes, such as DNA methylation changes or 
non-coding RNAs [60] (Figure 2). Finally, the experience of maltreatment during childhood may 
result in subsequent harsh and/or neglectful parenting in adulthood and this could be perpetuated 
across a number of generations.[64] These studies raise the possibility that antenatal, infant and 
childhood exposures may have consequences for multiple future generations. Indeed, 
intergenerational effects of the early life environment have been proposed as one mechanism to 
explain persisting health disparities amongst disadvantaged populations, potentially through effects on 
the HPA axis.[65, 66] 
 
Significance for paediatricians 
An understanding of early life programming and its consequences is of clear importance for 
paediatricians who are ideally placed to identify those most at risk of later disease and to facilitate the 
development and implementation of interventions. Given that adverse early life environments may 
affect not only children’s later life outcomes, but that of their own offspring, a paediatrician’s role 




Firstly, we can influence care from the beginning of life by emphasising the importance of good 
maternal health and antenatal care in optimising child and adult health. Addressing modifiable risk 
factors, including maternal obesity, excess gestational weight gain, maternal smoking and vitamin D 
levels and breastfeeding duration [10] could make a significant contribution to child health, and by 
implication, improve adult health. Indeed, paediatricians have been involved in the development of 
the National Institute for Health and Care Excellence evidence-based guidelines for the antenatal and 
postnatal care of women and babies (www.nice.org.uk) and these have been endorsed by the Royal 
College of Paediatrics and Child Health.  
 
Since any effects of the in utero environment may be amplified as a consequence of early growth 
patterns, optimising early nutrition may be a key way in which paediatricians can influence later 
health. In preterm babies, studies are ongoing to develop nutritional strategies which optimise 
neurodevelopment and prevent extrauterine growth restriction without promoting the development of 
longer term metabolic complications,[67] however there is much less evidence for the optimal 
nutritional management of the SGA infant born at, or near term,[68] or in the management of the 
offspring of obese women. Overweight and obese women are less likely than lean women to 
exclusively breastfeed at 2 months of age and are more likely to introduce early weaning foods.[69] 
Breastfeeding may be protective against childhood obesity as a consequence of reduced protein 
content compared to formula, the presence of active hormones such as leptin, ghrelin and adiponectin 
which may influence appetite control, and poorer regulation of satiety with bottle feeding.[39] Thus, 
the provision of additional support for breastfeeding and improving the food choices of these women 
has the potential to reduce childhood overweight and obesity, with obvious consequences for the next 
generation.[69]  
 
There is ongoing research (at present mainly in animal models) investigating therapeutic options to 
reverse or prevent the effects of in utero programming. Studies are ongoing to evaluate strategies for 
the prevention of CVD in individuals born with IUGR.[70] In animal studies, therapies which have 
been examined include micronutrient supplementation (eg. folate, glycine and choline) given during 
pregnancy to mitigate the effects of undernutrition, or statins for hypercholesterolaemia in pregnancy 
which may protect offspring against the conditioning effect of a high fat diet.[4] Similarly, there may 
be a role for leptin and statin therapy in those born SGA to modify the long-term hormonal and 
cardiovascular effects of an adverse antenatal environment.[4]  
 
Since programming effects may also occur as a consequence of experiences in infancy and childhood, 
targeted interventions during infancy and childhood may improve later health. For example a 
randomised controlled trial of the effects of additional support for single, poor, deprived mothers 
during pregnancy and first two years of life resulted in improved educational performance in 
9 
 
childhood, less substance abuse at 12 years, and less criminal behaviour at 19 years in their 
offspring.[71] Importantly, evidence suggests that such interventions also have the potential to 
improve health outcomes across generations.[65, 66] Paediatricians could have a key role in 
identifying the factors which lead to the perpetuation of effects and in designing and implementing 
interventions to interrupt these intergenerational cycles [60] (Figure 3). 
 
In conclusion, paediatricians are ideally placed to undertake research leading to an increased 
understanding of the mechanisms underpinning early life programming, to develop strategies for the 
early identification of disease risk and finally, to design and implement therapeutic strategies, with 
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Figure 1: Early life programming and later disease risk. Exposure to an adverse early life 
environment results in changes which may maximise short- and long-term survival but which can 
result in an increased risk of disease in later life. Such programmed effects may also include strategies 
to maximise reproductive success and population/species survival. 
 
 
Figure 2: Potential mechanisms accounting for the transgenerational transmission of disease 
risk. A) Persistence of an adverse environment leads to the re-induction of programmed effects in 
each subsequent generation. B) Maternal effects: the induction of programmed effects in the F1 
offspring following in utero exposure lead to the induction of programmed effects on the developing 
F2 fetus and so on. C) Exposure to an adverse environment affects the developing F1 fetus AND has 
direct effects on the germ cells which will form the F2 generation and these changes are maintained in 
the germ cells for a number of subsequent generations.    
 
Figure 3: Intergenerational cycle of disease risk. Early life programming may result in effects 
which persist across generations. Paediatricians are well-placed to identify those at risk and to develop 
and implement interventions at many points during the life-cycle.     
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